2020
DOI: 10.1016/j.biopha.2020.110732
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitory effects of polyphenols and their colonic metabolites on CYP2D6 enzyme using two different substrates

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 8 publications
(4 citation statements)
references
References 64 publications
0
4
0
Order By: Relevance
“…Polyphenols from Rhus verniciflua show inhibitory activity of AKR 1B10 from humans [ 29 ]. Plant polyphenols inhibit human cytochrome P450, another detoxifying enzyme [ 30 ]. AKR2E8 reduced benzaldehyde, hexanal, heptanal, nonanal, trans-2-nonenal, and citral present in mulberry leaves.…”
Section: Discussionmentioning
confidence: 99%
“…Polyphenols from Rhus verniciflua show inhibitory activity of AKR 1B10 from humans [ 29 ]. Plant polyphenols inhibit human cytochrome P450, another detoxifying enzyme [ 30 ]. AKR2E8 reduced benzaldehyde, hexanal, heptanal, nonanal, trans-2-nonenal, and citral present in mulberry leaves.…”
Section: Discussionmentioning
confidence: 99%
“…Other polyphenols (chrysin, quercetin, myricetin, acacetin, isorhamnetin, pinocembrin, tangeretin, naringenin, luteolin, diosmetin, fisetin, baicalein, kaempferol, resveratrol, bergamottin, chlorogenic acid, etc.) and their conjugated metabolites have also exhibited the ability to potently inhibit the catalytic activity of hepatic or intestinal cytochrome P450 enzymes (Fliszar‐Nyul et al., 2020; Mohos, Fliszar‐Nyul, Ungvari, Bakos, et al., 2020; Ostlund et al., 2017; Santes‐Palacios et al., 2020; Saric Mustapic et al., 2018).…”
Section: Current Strategies For Improving Bioavailability Of Nutraceu...mentioning
confidence: 99%
“…CYP enzymes and some proteins having pharmacokinetic significance may interact with a variety of natural compounds during metabolic transformation and this causes food–drug interactions 16 . There are reports dealing with the interactions of some flavonoids with biotransformation including CYP enzymes 17,18 .…”
Section: Introductionmentioning
confidence: 99%
“…15 CYP enzymes and some proteins having pharmacokinetic significance may interact with a variety of natural compounds during metabolic transformation and this causes food-drug interactions. 16 There are reports dealing with the interactions of some flavonoids with biotransformation including CYP enzymes. 17,18 The significance of the CYP2D6 enzyme in metabolism was identified by the United States Food and Drug Administration (FDA), therefore the need for extensive and detailed studies in this field has also been implied.…”
Section: Introductionmentioning
confidence: 99%